[go: up one dir, main page]

MXPA02011480A - Derivados de disulfuro de anilina para tratar enfermedades alergicas. - Google Patents

Derivados de disulfuro de anilina para tratar enfermedades alergicas.

Info

Publication number
MXPA02011480A
MXPA02011480A MXPA02011480A MXPA02011480A MXPA02011480A MX PA02011480 A MXPA02011480 A MX PA02011480A MX PA02011480 A MXPA02011480 A MX PA02011480A MX PA02011480 A MXPA02011480 A MX PA02011480A MX PA02011480 A MXPA02011480 A MX PA02011480A
Authority
MX
Mexico
Prior art keywords
allergic diseases
treating allergic
disulfide derivatives
preventing
aniline
Prior art date
Application number
MXPA02011480A
Other languages
English (en)
Inventor
Mark R Hellberg
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA02011480A publication Critical patent/MXPA02011480A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describen métodos y composiciones para prevenir o tratar enfermedades alérgicas del ojo, nariz, piel, oído, tracto gastrointestinal, vías respiratorias o pulmon y prevenir o tratar manifestaciones de mastocitosis sistémica; las composiciones contienen un derivado de disulfuro estabilizador de mastocito como un ingrediente activo.
MXPA02011480A 2000-05-19 2001-04-25 Derivados de disulfuro de anilina para tratar enfermedades alergicas. MXPA02011480A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20574600P 2000-05-19 2000-05-19
PCT/US2001/013242 WO2001090059A1 (en) 2000-05-19 2001-04-25 Aniline disulfide derivatives for treating allergic diseases

Publications (1)

Publication Number Publication Date
MXPA02011480A true MXPA02011480A (es) 2003-06-06

Family

ID=22763478

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011480A MXPA02011480A (es) 2000-05-19 2001-04-25 Derivados de disulfuro de anilina para tratar enfermedades alergicas.

Country Status (19)

Country Link
US (2) US6372802B2 (es)
EP (1) EP1289945B1 (es)
JP (1) JP2003534317A (es)
KR (1) KR20020093982A (es)
CN (1) CN1173697C (es)
AR (1) AR028565A1 (es)
AT (1) ATE272619T1 (es)
AU (2) AU5722701A (es)
BR (1) BR0110845A (es)
CA (1) CA2408145A1 (es)
DE (1) DE60104690T2 (es)
DK (1) DK1289945T3 (es)
ES (1) ES2222370T3 (es)
MX (1) MXPA02011480A (es)
PL (1) PL365459A1 (es)
PT (1) PT1289945E (es)
TR (1) TR200402299T4 (es)
WO (1) WO2001090059A1 (es)
ZA (1) ZA200208839B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
CA2567156A1 (en) * 2004-05-17 2006-07-20 Cambrios Technology Corp. Biofabrication of transistors including field effect transistors
KR20070024618A (ko) * 2004-06-28 2007-03-02 알콘, 인코퍼레이티드 알레르기성 질환 치료용 국소 제제
US20130304180A1 (en) * 2012-05-09 2013-11-14 Michael L. Green Catheter having dual balloon hydraulic actuator
US11058444B2 (en) 2017-12-11 2021-07-13 Covidien Lp Electrically enhanced retrieval of material from vessel lumens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (es) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0006227B1 (en) * 1978-06-16 1984-12-27 Kyowa Hakko Kogyo Co., Ltd Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
JPS59205356A (ja) * 1983-05-10 1984-11-20 Teikoku Hormone Mfg Co Ltd ジスルフアニルベンゼン酢酸誘導体
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH08253454A (ja) * 1994-12-26 1996-10-01 Nisshin Flour Milling Co Ltd ジフェニルジスルフィド化合物
JPH095926A (ja) 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU2458697A (en) 1996-04-18 1997-11-07 Alcon Laboratories, Inc. Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
JP2894445B2 (ja) * 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸
JP3702382B2 (ja) * 1997-10-22 2005-10-05 参天製薬株式会社 ＮＦ−κＢ活性化阻害剤
ATE302601T1 (de) * 2000-05-19 2005-09-15 Alcon Inc Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten
MXPA02011481A (es) * 2000-05-19 2003-06-06 Alcon Inc Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.
JP2002193796A (ja) * 2000-12-27 2002-07-10 Ajinomoto Co Inc 炎症因子活性化抑制剤、その用途及びそのために使用可能な新規ポリスルフィド誘導体

Also Published As

Publication number Publication date
TR200402299T4 (tr) 2004-12-21
US6372802B2 (en) 2002-04-16
AU2001257227B2 (en) 2005-04-07
CN1173697C (zh) 2004-11-03
HK1050677A1 (en) 2003-07-04
EP1289945A1 (en) 2003-03-12
US6452052B1 (en) 2002-09-17
ATE272619T1 (de) 2004-08-15
PL365459A1 (en) 2005-01-10
DE60104690D1 (de) 2004-09-09
CN1429208A (zh) 2003-07-09
EP1289945B1 (en) 2004-08-04
WO2001090059A1 (en) 2001-11-29
PT1289945E (pt) 2004-10-29
DK1289945T3 (da) 2004-11-01
US20020115658A1 (en) 2002-08-22
DE60104690T2 (de) 2005-01-13
US20020013311A1 (en) 2002-01-31
KR20020093982A (ko) 2002-12-16
JP2003534317A (ja) 2003-11-18
ZA200208839B (en) 2004-02-03
AR028565A1 (es) 2003-05-14
CA2408145A1 (en) 2001-11-29
BR0110845A (pt) 2003-02-11
AU5722701A (en) 2001-12-03
ES2222370T3 (es) 2005-02-01

Similar Documents

Publication Publication Date Title
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
EP1797881A4 (en) MEDICAL COMPOSITION
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
AU2002331391A1 (en) N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents
WO1998040069A3 (en) Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
CY1110664T1 (el) Ενδορινικες συνθεσετς
AU2003245812A1 (en) Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
AU2003201745A1 (en) Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
EP2170857A4 (en) 3 ', 4', 5-TRIMETHOXYFLAVONE DERIVATIVES AS THE SLEEP SECRETION STIMULATING AGENT, CORRESPONDING METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
SE9704644D0 (sv) New use
PL365459A1 (en) Aniline disulfide derivatives for treating allergic diseases
HK1038694A1 (zh) 治疗眼、耳、鼻病症的抗生素合成剂
WO2003072030A3 (en) Methods for preventing or treating cardiac arrhythmia
NO20064521L (no) Framgangsmate og blanding for behandling av rhinitt
WO2004091591A3 (fr) Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives
WO2004087167A3 (en) Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
MXPA02011481A (es) Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.
MXPA02011482A (es) Composiciones que contienen un derivado de disulfuro de benzamida para tratar enfermedades.
WO2001034129A3 (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
AU2003274785A1 (en) Use of 3-position cyclosporin derivatives for hair growth
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient
AU2001261748A1 (en) Antibiotic compositions for treatment of the eye, ear and nose
WO2005105081A3 (en) Therapeutic formulations of desoxyepothilones

Legal Events

Date Code Title Description
FG Grant or registration